logo
  • About
  • Plus Three
  • Power Trip
  • Store
  • Donate
  • Search

Tehseen Noorani

Tehseen Noorani, PhD is a Marie Curie and Durham University COFUND Junior Research Fellow. His research investigates the social, political and epistemic potential of trauma, illness and drugs in producing 'limit-experiences'. From 2013-2015 Tehseen was a NIDA-funded postdoctoral research fellow on at Johns Hopkins University, where he led qualitative research for a pharmacology team researching psychedelic experiences. He is currently conducting a comparative ethnography of psychedelics use, and has taught at New York University and the University of East London.


[molongui_author_posts count=100 list_divider=”yes” show_date=”yes”]

How Psychedelic Science Privileges Some, Neglects Others, and Limits Us All

September 20, 2017

There is an urgent need for cultural humility in psychedelic science in order to prevent it from falling into the same limiting, and often unethical, traps that we see in Western science and medicine.


What the Scientologists can teach us about drug reform

September 22, 2017

Even with its straightforward-sounding name, the Foundation for a Drug-Free World (FDFW) hides plenty beneath the surface—namely, a direct connection to the Church of Scientology.


Breathe. Breathe. Breathe. An Interview with Iker Puente on Holotropic Breathwork

September 26, 2017

Holotropic Breathwork is not just a breath technique. It was conceived as a non-drug way of accessing non-ordinary states of consciousness.


I was in the MAPS MDMA for PTSD study. It freed me from a childhood of abuse.

October 3, 2017

MDMA-assisted psychotherapy gave me the ability to feel compassion and empathy for myself.


What’s so controversial about microdosing?

October 4, 2017

The incredible mainstream press microdosing has received has managed to avoid many discussions.


This british conservative thinks drug prohibition is as intelligent as alcohol prohibition in US

October 23, 2017

Crispin Blunt suggested that legally regulating cannabis may well drag UK drug policy out of the dark ages.


Psychedelics and Mental Health

October 25, 2017

Depression. Anxiety. Addiction. Most everyone of us knows somebody who is battling such a condition. Talk therapies may help, but sometimes they don’t. Antidepressants may help, but sometimes they don’t. Some patients are of the opinion that antidepressants are like “Band-Aids” in the way that they never really tackle the underlying issues of their problems.


The State: Friday, Oct 27, 2017

October 27, 2017

To get a vision of the future of psychedelics from a legal and regulatory perspective, the most useful thing to do might be to see what's happening already in the realm of weed.


International Drug Policy Reform Conference Brings Harm Reduction into Spotlight

October 30, 2017

My destination was the International Drug Policy Reform Conference (Reform 2017). Judging by the throng of young college students crowding the lobby, I knew we were in the right place.


Fear and Loathing on Flatbush Avenue

October 31, 2017

Fear and Loathing in Las Vegas can tell us a lot about the building of the system we are now finding ourselves stuck inside.


Loading…

Join Our Newsletter

Independent reporting. Critical analysis. In your inbox.

Text

About
Donate

Store
Power Trip
Plus Three Podcast

Text

Media Requests
Send Us A Tip
Editorial Policy
Subscribe
Archive

Image

Text

Text

About
Donate

Store
Power Trip
Plus Three Podcast

Text

Media Requests
Send Us A Tip
Editorial Policy
Subscribe
Archive

Image

Psymposia is a 501(c)(3) non-profit media organization that offers critical perspectives on drugs, politics, and culture. We reject corporate advertising and rely on contributions from our readers and listeners. Click here to donate today.

Privacy. Terms of Use. © Psymposia, Inc. All Rights Reserved

Image

Text

About
Donate
Store
Power Trip
Podcast

Media Requests
Send Us A Tip

Editorial Policy
Subscribe
Archive

Privacy
Terms of Use

Psymposia is a 501(c)(3) non-profit media organization that offers leftist perspectives on drugs, politics, and culture. We reject corporate advertising and rely on contributions from our readers and listeners. Click here to donate today.

© Psymposia, Inc. All Rights Reserved

Image

Image

Text

About
Donate
Store
Power Trip
Podcast

Media Requests
Send Us A Tip

Editorial Policy
Subscribe
Archive

Privacy
Terms of Use

Psymposia is a 501(c)(3) non-profit media organization that offers leftist perspectives on drugs, politics, and culture. We reject corporate advertising and rely on contributions from our readers and listeners. Click here to donate today.

© Psymposia, Inc. All Rights Reserved

Image

  • About
  • Power Trip
  • Plus Three
  • Store
  • Support us on Patreon
  • Donate
  • Psychedelics
  • Corporadelic
  • Culture
  • Ethics
  • Series
  • Editorial Policies
  • Subscribe
  • Submissions
  • Send Us a Tip
  • Media Requests
  • Archive

Psymposia is a 501(c)(3) research non-profit with a mission to educate the public on psychedelic science and harm reduction.

Privacy Terms of Use

shiftnav-1

  • About
  • Plus Three
  • Power Trip
  • Store
  • Donate